Guo Hui obtained doctoral degree in Oncology and completed postdoctoral research in bioengineering at Xi'an Jiaotong University (XJTU). As a national visiting fellow, she studied at MD Anderson Cancer Center in U.S. She is currently Deputy Director of Department of Oncology of the FAH of XJTU and Vice President of School of Life Sciences and Technology of XJTU. For years, she has been devoted to clinical diagnosis and treatment of malignant tumors, and has been engaged in basic and clinical research on the pathogenesis and comprehensive treatment of lung cancer and digestive tract tumors. She has hosted multiple national scientific research projects, undertaken national clinical research on new drugs and international multi-center clinical cooperation projects.

Deputy Head  Youth Group of Chinese Society of Oncology of Chinese Medical Association

Member  Board of Directors of Chinese Society of Clinical Oncology (CSCO)

Member  Young Expert Committee of CSCO

Member  Professional Committee of Patient Education of CSCO

Member  Professional Committee of Rare Tumors of CSCO

Member  Expert Committee of Safety Management of Anti-tumor Drugs of  CSCO

Member  Professional Committee of Precision Medicine of China Association of Rehabilitation Technology Transformation & Promotion (CARTTP)

Chairman-designate  Professional Committee of Translational Medicine of Shaanxi Anti-cancer Association

Vice Chairman  Professional Committee of Liver Cancer of Cancer Prevention and Control Alliance of Shaanxi Province

Standing Committee Member  Professional Committee of Chemotherapy of Shaanxi Anti-cancer Association

Guo Hui has obtained the second prize of National Science and Technology Progress Award, the second prize of Science and Technology Progress Award of the Ministry of Education, Youth Science and Technology Pace–setter of Shaanxi Province and multiple scientific research honors. She has hosted multiple surface projects of National Natural Science Foundation of China, National Key Research and Development Project and Distinguished Youth Scholar Project of Shaanxi Province, etc. She also led the team to receive multiple honorary titles, such as Sanqin Scholar Innovation Team of Shaanxi Province and Multidisciplinary Team of Tumor Immunotherapy and Physical Microenvironment, etc. 

Guo Hui has participated in drafting Chinese expert consensus on the diagnosis and treatment of HER2-mutated non-small cell lung cancer, Management of stage III non-small cell lung cancer: consensus and validation, and Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma and multiple national expert consensuses.Relevant research outcomes have been published in 102 papers in SCI-indexed journals, including 50 papers as the first/co-first/corresponding/co-corresponding authors, such as Materials Today, Trends Cell Biol and Hepatology, etc.

She has participated in drafting 3 monographs, including Modern Oncology Therapeutics, Targeted Therapy for Malignant Tumors and 100 Questions and Answers for Tumor Immunotherapy. She was invited as invited editor of Advanced Drug Delivery Reviews and Frontiers in Pharmacology, and served as editorial board member of Translational Cancer Research, Journal of Modern Oncology and Clinical Medical Practice, etc. She also participated in 4 invention patents.

Guo Hui has obtained 1 second prize of National Teaching Achievement Award, 1 second prize of National Science and Technology Progress Award, 1 second prize of Science and Technology Progress Award of the Ministry of Education, 1 second prize of Science and Technology Progress Award of Shaanxi Province and 2 Excellent Natural Science Dissertation of Shaanxi Province. She also received the honorary titles of Outstanding Youth Foundation of Shaanxi Province, Youth Science and Technology Pace–setter of Shaanxi Province , Young and Middle-aged Leading Talents of Scientific and Technological Innovation of Shaanxi Province, and Academic Leader of "Sanqin Team" of Shaanxi Province.